Diabetes Drugs and Eye Disease: These Protect, These Don’t
TOPLINE:Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and fenofibrates are associated with a reduced risk for diabetic macular edema (DME)...
Elida Guillemette
TOPLINE:Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and fenofibrates are associated with a reduced risk for diabetic macular edema (DME)...
